Pfizer/BioNTech jab safe for children aged five to 11
The positive trial results could pave the way for vaccinating children younger than 12, if approved. …
Dr Ugur Sahin, CEO and co-founder of BioNTech, said: “The safety profile and immunogenicity data in children aged five to 11 years vaccinated at a lower dose are consistent with those we have observed with our vaccine in other older populations at a higher dose.
About The Author
